An investigation of the effects of photobiomodulation (PBM) therapy on post-operative pain and functional mobility in people undergoing knee replacement surgery (a randomised, sham-controlled study).

Mater Misericordiae Limited0 个研究点目标入组 60 人开始时间: 2022年1月17日最近更新: 2023年1月16日

适应症

试验速览

暂无简介。

•Males and females between 60 and 87 years old and fit for surgery
•Undergoing unilateral total knee replacement surgery for severe osteoarthritis at the Mater Hospital Brisbane or Mater Private Hospital Brisbane

•Coagulopathy
•Pre-existing pain syndrome such as peripheral neuropathy
•Previous history of stroke
•Previous surgery/severe trauma of the operated knee
•Neuromuscular disease significantly affecting the operated knee
•Severe back pain and arthritis significantly affecting mobility or referring pain to the operated leg
•Significant cognitive dysfunction that may prevent ability to consent to participation in the study (people of a non-English speaking background will NOT be excluded if a reliable interpreter will be available to assist with explaining the study requirements, taking part in outcome questionnaires etc)
•Medical diagnosis of significant mental ill health (e.g., severe depression, anxiety, catastrophising etc) which may impact upon recovery period
•Photosensitising agents (drugs)
•Tumour at the knee or thigh where patches will be applied
•Skin sensitivity to medical adhesives

发起方

Mater Misericordiae Limited